Tarceva Tablet 100 mg Singapore - English - HSA (Health Sciences Authority)

tarceva tablet 100 mg

roche singapore pte. ltd. - erlotinib hydrochloride eqv. erlotinib - tablet, film coated - 100mg - erlotinib hydrochloride eqv. erlotinib 100mg

Tarceva Tablet 150 mg Singapore - English - HSA (Health Sciences Authority)

tarceva tablet 150 mg

roche singapore pte. ltd. - erlotinib hydrochloride 163.93 mg eqv erlotinib - tablet, film coated - 150 mg - erlotinib hydrochloride 163.93 mg eqv erlotinib 150 mg

ALVOCEVA FILM-COATED TABLETS 100MG Singapore - English - HSA (Health Sciences Authority)

alvoceva film-coated tablets 100mg

lotus international pte. ltd. - erlotinib hydrochloride eqv erlotinib - tablet, film coated - erlotinib hydrochloride eqv erlotinib 100.00 mg

ALVOCEVA FILM-COATED TABLETS 150MG Singapore - English - HSA (Health Sciences Authority)

alvoceva film-coated tablets 150mg

lotus international pte. ltd. - erlotinib hydrochloride eqv erlotinib - tablet, film coated - erlotinib hydrochloride eqv erlotinib 150.00mg

Tarceva European Union - English - EMA (European Medicines Agency)

tarceva

roche registration gmbh - erlotinib - carcinoma, non-small-cell lung; pancreatic neoplasms - antineoplastic agents - non-small cell lung cancer (nsclc)tarceva is also indicated for switch maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with egfr activating mutations and stable disease after first-line chemotherapy.tarceva is also indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.in patients with tumours without egfr activating mutations, tarceva is indicated when other treatment options are not considered suitable.when prescribing tarceva, factors associated with prolonged survival should be taken into account.no survival benefit or other clinically relevant effects of the treatment have been demonstrated in patients with epidermal growth factor receptor (egfr)-ihc - negative tumours.pancreatic cancertarceva in combination with gemcitabine is indicated for the treatment of patients with metastatic pancreatic cancer.when prescribing tarceva, factors associated with prolonged survival should be taken into account.

TARCEVA TABLET Canada - English - Health Canada

tarceva tablet

hoffmann-la roche limited - erlotinib (erlotinib hydrochloride) - tablet - 25mg - erlotinib (erlotinib hydrochloride) 25mg - antineoplastic agents

TARCEVA TABLET Canada - English - Health Canada

tarceva tablet

hoffmann-la roche limited - erlotinib (erlotinib hydrochloride) - tablet - 100mg - erlotinib (erlotinib hydrochloride) 100mg - antineoplastic agents

TARCEVA TABLET Canada - English - Health Canada

tarceva tablet

hoffmann-la roche limited - erlotinib (erlotinib hydrochloride) - tablet - 150mg - erlotinib (erlotinib hydrochloride) 150mg - antineoplastic agents

TEVA-ERLOTINIB TABLET Canada - English - Health Canada

teva-erlotinib tablet

teva canada limited - erlotinib (erlotinib hydrochloride) - tablet - 25mg - erlotinib (erlotinib hydrochloride) 25mg - antineoplastic agents

TEVA-ERLOTINIB TABLET Canada - English - Health Canada

teva-erlotinib tablet

teva canada limited - erlotinib (erlotinib hydrochloride) - tablet - 100mg - erlotinib (erlotinib hydrochloride) 100mg - antineoplastic agents